Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
about
Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitisIn vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae.In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents.High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA.Can fluoroquinolones be considered once-daily therapy?
P2860
Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of quinolones in the trea ...... community-acquired pneumonia.
@en
Role of quinolones in the trea ...... community-acquired pneumonia.
@nl
type
label
Role of quinolones in the trea ...... community-acquired pneumonia.
@en
Role of quinolones in the trea ...... community-acquired pneumonia.
@nl
prefLabel
Role of quinolones in the trea ...... community-acquired pneumonia.
@en
Role of quinolones in the trea ...... community-acquired pneumonia.
@nl
P2093
P2860
P356
P1476
Role of quinolones in the trea ...... community-acquired pneumonia.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF01967004
P577
1991-04-01T00:00:00Z